Ageing Research Reviews, 2005
The Rest of Europe region, including Nordic countries, Eastern Europe, Belgium, Switzerland, and Austria, is anticipated to hold 16.6% in 2025, declining slightly to 16.3% by 2035, attributed to mixed growth patterns with strong expansion in some healthcare markets balanced by moderate growth in smaller countries implementing diabetes care development programs
'Tip of the Iceberg' Obesity drugs are likely to have a ripple effect in the healthcare sector far beyond weight management
It helps with DNA production, fatty acid synthesis, and energy
More Reads
Researchers can use IGF1 LR3 to study the cell-level pathways involved in muscle stem cell start, proliferation, and differentiation, providing insights that have implications for grasp muscle growth, aging-related muscle loss, and possible treatment approaches to muscle wasting conditions